Skip to main content
Watch Insiders
RDHLSector not reported

Redhill Biopharma Ltd. - ADR (RDHL) Insider Trading

In the last 90 days, 1 Redhill Biopharma Ltd. - ADR (RDHL) insider reported no open-market purchases and 1 sale totaling $1,431. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Gilead RadayChief Operating OfficerSale14,310,000$0.00$1,431
Jul 10, 2026Gilead RadayChief Operating OfficerSale14,130,000$0.00$1,413
Apr 6, 2026Gilead RadayChief Operating OfficerSale15,740,000$0.00$1,574

Common questions

RDHL insider trading FAQ

Are RDHL insiders buying or selling?
Over the last 90 days, RDHL insiders were net sellers, reporting $0.00 of open-market purchases and $1,431 of sales.
When was the last RDHL insider purchase?
No open-market insider purchase of Redhill Biopharma Ltd. - ADR stock was reported in the last 90 days.
Where does RDHL insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Redhill Biopharma Ltd. - ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.